3-Year Outcomes of Mitral Valve-in-Valve Therapy Using Balloon-Expandable Transcatheter Valves in the United States

By afschroeder • June 12, 2025

Eleid MF, Krishnaswamy A, Kapadia S, Yadav P, Rajagopal V, Makkar R, Stinis C, Chetcuti S, Morse A, Frisoli T, Frangieh AH, Abbas AE, Whisenant B, O'Neill WW, Guerrero ME, Rodriguez E, Kodali S, Ailawadi G, Rihal CS. 3-Year Outcomes of Mitral Valve-in-Valve Therapy Using Balloon-Expandable Transcatheter Valves in the United States. JACC Cardiovasc Interv. 2025 Jun 9;18(11):1454-1466. doi: 10.1016/j.jcin.2025.03.017. PMID: 40500016.

Tags: bioprosthetic mitral degeneration, Cardiology/Epi, Cedars Sinai DoM, mitral valve reintervention, mitral valve-in-valve procedure, Publications, Society for Thoracic Surgeons, Transcatheter Valve Therapy Registry, transseptal approach

Related Posts

Heart Failure Quality of Care Among Asian Patients in the United States

Huang X, Huffman MD, Kandula NR, Petito LC, Agarwal A, Yancy CW, Fonarow GC, Jhund PS, Mefford MT, Reynolds KL, Khan SS, Shah NS. Heart[...]

Public Reporting of Quality and Clinical Outcomes in the Get With The Guidelines-Stroke Registry

Mullen MT, Zhao J, Jiang T, Gao Z, Buechner J, Wahab F, Seo MH, Harder B, Schwamm LH, Fonarow GC, Smith EE, Xian Y, Messé[...]

Myeloid Fmr1 deficiency in mice results in reduced serum cholesterol and altered bile pathway gene expression

Zhao X, Zhou J, Chyu KY, Erbay E, Cercek B, Shah PK, Dimayuga PC. Myeloid Fmr1 deficiency in mice results in reduced serum cholesterol and[...]